Abstract:Backgroundγδ T cells are a distinct subgroup of T cells containing T cell receptors (TCRs) γ and TCR δ chains with diverse structural and functional heterogeneity. As a bridge between the innate and adaptive immune systems, γδ T cells participate in various immune responses during cancer progression. Because of their direct/indirect antitumor cytotoxicity and strong cytokine production ability, the use of γδ T cells in cancer immunotherapy has received a lot of attention over the past decade.Main textDespite the promising potential of γδ T cells, the efficacy of γδ T cell immunotherapy is limited, with an average response ratio of only 21%. In addition, research over the past 2 years has shown that γδ T cells could also promote cancer progression by inhibiting antitumor responses, and enhancing cancer angiogenesis. As a result, γδ T cells have a dual effect and can therefore be considered as being both “friends” and “foes” of cancer. In order to solve the sub-optimal efficiency problem of γδ T cell immunotherapy, we review recent observations regarding the antitumor and protumor activities of major structural and functional subsets of human γδ T cells, describing how these subsets are activated and polarized, and how these events relate to subsequent effects in cancer immunity. A mixture of both antitumor or protumor γδ T cells used in adoptive immunotherapy, coupled with the fact that γδ T cells can be polarized from antitumor cells to protumor cells appear to be the likely reasons for the mild efficacy seen with γδ T cells.ConclusionThe future holds the promise of depleting the specific protumor γδ T cell subgroup before therapy, choosing multi-immunocyte adoptive therapy, modifying the cytokine balance in the cancer microenvironment, and using a combination of γδ T cells adoptive immunotherapy with immune checkpoint inhibitors.

Human Γδt-Cell Subsets and Their Involvement in Tumor Immunity.

Human Gamma Delta T-Cell Subsets And Their Involvement In Tumor Immunity

Effect of γδT Cells in Tumor

Expansion and Immunological Study of Human Tumor Infiltrating Gamma/Delta T Lymphocytes in vitro<sup>1</sup>

Expansion and Immunological Study of Human Tumor Infiltrating Gamma/Delta T Lymphocytes in Vitro

The Microbiota is a Potential Mediator of the Crosstalk Between Γδ T Cells and Tumors

In Respond To Commensal Bacteria: Gamma Delta T Cells Play A Pleiotropic Role In Tumor Immunity

In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy

Function and Spatial Organization of Tumor‐Invasive Human γδ T Cells—What Do We Know?

γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells

Research Progress of γδT Cells in Tumor Immunotherapy

γδ T cells as critical anti-tumor immune effectors

Function of γδ T cells in tumor immunology and their application to cancer therapy

Gamma-delta (γδ) T cells: friend or foe in cancer development?

The capability of heterogeneous γδ T cells in cancer treatment

γδT Cells and Related Diseases.

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion

Pro‐ and antitumorigenic functions of γδ T cells

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations

Potential of gamma/delta T cells for solid tumor immunotherapy